Progress in Neuro-Psychopharmacology and Biological Psychiatry

SJR Rank #2,444H-index: 165SJR: 1.502Best quartile: Q1APC: US$4,380
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Biological PsychiatryQ1
  • PharmacologyQ1

Areas: Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersNeuroscience and Neuropharmacology ResearchSchizophrenia research and treatmentStress Responses and CortisolBipolar Disorder and TreatmentTreatment of Major DepressionFunctional Brain Connectivity StudiesReceptor Mechanisms and SignalingNeuroendocrine regulation and behavior

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

202220250100200300400

Detailed Information

ISSN

1878-4216, 0278-5846

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.93

References per Document

87.49

Coverage

1982-2026

Scope

Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.

Metrics from SCImago Journal Rank 2025. View on SCImago